The abstract is read at the publisher; the summary is JClub's.
Nanobodies (single-domain antibodies/VHHs) from camelids are versatile antigen-binding modules whose structural and biochemical properties enable modular next-generation biologics across multiple application areas.
- Why it matters: Conventional antibody formats can limit design flexibility, stability, and practical deployment, motivating broader tools for biotechnology, diagnostics, and therapeutics.
- What they did: This review synthesizes advances in nanobody generation, physicochemical traits, manufacturability, stability, immunogenicity, antigen recognition, functional modulation, and engineering flexibility, including multivalent/multispecific constructs and half-life extension strategies.
- The result: The paper summarizes how engineered nanobodies—alone or as fusions such as immunotoxins, imaging agents, and CAR T cell constructs—support diverse therapeutic and diagnostic designs.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.